Syndax Pharmaceuticals (SNDX) Interest & Investment Income (2016 - 2017)
Historic Interest & Investment Income for Syndax Pharmaceuticals (SNDX) over the last 3 years, with Q4 2017 value amounting to $462000.0.
- Syndax Pharmaceuticals' Interest & Investment Income rose 7238.81% to $462000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $1.4 million, marking a year-over-year increase of 4874.48%. This contributed to the annual value of $26.1 million for FY2024, which is 2328.12% up from last year.
- Per Syndax Pharmaceuticals' latest filing, its Interest & Investment Income stood at $462000.0 for Q4 2017, which was up 7238.81% from $411000.0 recorded in Q3 2017.
- Over the past 5 years, Syndax Pharmaceuticals' Interest & Investment Income peaked at $462000.0 during Q4 2017, and registered a low of -$524000.0 during Q4 2015.
- In the last 3 years, Syndax Pharmaceuticals' Interest & Investment Income had a median value of $268000.0 in 2016 and averaged $118454.5.
- Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 21703.06% in 2016, then soared by 507.25% in 2017.
- Over the past 3 years, Syndax Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$524000.0 in 2015, then soared by 151.15% to $268000.0 in 2016, then soared by 72.39% to $462000.0 in 2017.
- Its last three reported values are $462000.0 in Q4 2017, $411000.0 for Q3 2017, and $290000.0 during Q2 2017.